GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lyell Immunopharma LYEL · USD

Health Care · US listing · 🇺🇸 United States

Compare

15.42

+3.77%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Lyell Immunopharma and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Lyell Immunopharma LYEL 15.42$263.6m—-762355.6%— +3.77%
Zevra Therapeutics ZVRA 12.14$683.5m7.678.2%— +4.75%
SIGA Technologies SIGA 3.26$234.4m9.724.6%19.05% +5.16%
Kamada KMDA 7.71$444.7m21.211.2%2.29% +6.64%
4D Molecular Therapeutics FDMT 12.48$636.6m—-164.4%— +1.88%
Rocket Pharmaceuticals RCKT 2.53$281.1m——— +6.30%
ADC Therapeutics ADCT 1.67$206.9m—-175.3%— +5.70%
Organogenesis Holdings ORGO 0.91$119.4m3.16.6%— +11.55%
Elite Pharmaceuticals ELTP 0.24$256.4m5.730.1%— +0.97%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.